Related Experiment Video
Updated: Aug 27, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Elucidating the neuropathological and molecular heterogeneity of amyloid beta and tau in Alzheimer's disease through
Kanhao Zhao1,2, Hua Xie3,4, Tovia Jacobs5
1Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA.
Introduction:
Functional brain network alterations associated with Alzheimer's disease (AD) pathology, including amyloid beta (Aβ) and phosphorylated tau (p-tau), are difficult to interpret due to overlapping aging-associated and non-amyloid biological processes.
Methods:
We analyzed resting-state functional magnetic resonance imaging (fMRI) from 289 older adults classified as Aβ-positive (A+, n = 129) or Aβ-negative (A-, n = 160) based on cerebrospinal fluid biomarkers. A contrastive deep learning framework was used to identify A+-specific network dimensions and predict individual Aβ and p-tau levels.
Results:
A+-specific signatures were localized to the right superior temporal and anterior cingulate cortices and linked to attention and memory functions, with transcriptomic enrichment implicating synaptic dysfunction and glial activity. In contrast, signature dimensions shared between A+ and A- individuals involved language-related regions and aging-associated molecular pathways.
Conclusion:
These findings suggest that contrastive graph learning may help separate amyloid-associated functional network variation from broader background biological variability, providing insight into the heterogeneity of AD-related biomarkers and cognitive dysfunction.
More Related Videos
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
09:00Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction